1. Home
  2. WAY vs BLCO Comparison

WAY vs BLCO Comparison

Compare WAY & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waystar Holding Corp.

WAY

Waystar Holding Corp.

HOLD

Current Price

$34.25

Market Cap

6.7B

Sector

N/A

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.27

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAY
BLCO
Founded
1999
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Ophthalmic Goods
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.0B
IPO Year
2024
2022

Fundamental Metrics

Financial Performance
Metric
WAY
BLCO
Price
$34.25
$17.27
Analyst Decision
Strong Buy
Hold
Analyst Count
15
14
Target Price
$46.53
$17.31
AVG Volume (30 Days)
1.8M
361.8K
Earning Date
02-17-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
$1,039,842,000.00
$4,976,000,000.00
Revenue This Year
$16.69
$8.06
Revenue Next Year
$17.44
$5.79
P/E Ratio
$55.47
N/A
Revenue Growth
14.76
6.23
52 Week Low
$29.40
$10.45
52 Week High
$48.11
$18.14

Technical Indicators

Market Signals
Indicator
WAY
BLCO
Relative Strength Index (RSI) 56.02 58.68
Support Level $31.13 $16.22
Resistance Level $33.72 $17.55
Average True Range (ATR) 0.82 0.35
MACD 0.28 -0.02
Stochastic Oscillator 98.45 78.20

Price Performance

Historical Comparison
WAY
BLCO

About WAY Waystar Holding Corp.

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: